Mental Health Clinical Research Innovations during the COVID-19 Pandemic: The Future Is Now

TY - JOUR

T1 - Mental Health Clinical Research Innovations during the COVID-19 Pandemic

T2 - The Future Is Now

AU - Ahern, Kelly B.

AU - Lenze, Eric J.

N1 - Funding Information: Dr E.J. Lenze: Grant support (nonfederal): COVID Early Treatment Fund , Mercatus Center Emergent Ventures , the Skoll Foundation , the Taylor Family Institute for Innovative Psychiatric Research , the Center for Brain Research in Mood Disorders , the Patient-Centered Outcomes Research Institute , and the Barnes Jewish Foundation . Consulting fees: Janssen and Jazz Pharmaceuticals. Patent: Has applied for a patent for the use of fluvoxamine in the treatment of COVID-19. Ms K.B. Ahern has nothing to disclose.

PY - 2022/3

Y1 - 2022/3

KW - COVID-19

KW - Decentralized

KW - Fluvoxamine

KW - Remote

KW - Trials

UR - http://www.scopus.com/inward/record.url?scp=85123738933&partnerID=8YFLogxK

U2 - 10.1016/j.psc.2021.11.011

DO - 10.1016/j.psc.2021.11.011

M3 - Review article

C2 - 35219437

AN - SCOPUS:85123738933

SN - 0193-953X

VL - 45

SP - 179

EP - 189

JO - Psychiatric Clinics of North America

JF - Psychiatric Clinics of North America

IS - 1

ER -